Skip to content

Clinical trials

Phase 2 Prostatic Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 2 Country / region: Germany Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20041
20052
20063
20074
20083
20091
20102
20114
20123
20131
20146
20161
20174
20201
20244
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated7
Recruiting5
Active, not recruiting4
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Astellas Pharma Inc4
Bristol-Myers Squibb3
Eli Lilly and Company3
Ferring Pharmaceuticals3
Heidelberg University3
Astellas Pharma Global Development, Inc.2
Bayer2
Centocor, Inc.2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms48
Neoplasms4
Esophageal Neoplasms2
Neoplasm Metastasis2
Ovarian Neoplasms2
Pancreatic Neoplasms2
Uterine Cervical Neoplasms2
Abdominal Neoplasms1
Anus Neoplasms1
Breast Neoplasms1

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.